利多卡因軟膏市場：按配方、年齡組、應用、分銷渠道、地區 - 規模、份額、展望、機會分析，2022-2030 年

外用利多卡因軟膏用於身體的各個部位，使正在接受某些醫療程序（例如手術）的患者麻木。 它還用於緩解由曬傷、常春籐、漆樹和輕微割傷和擦傷等情況引起的疼痛和瘙癢。 它也被男性和女性用於預防和控制尿道手術期間的疼痛。

利多卡因通常用作局部麻醉劑，但也用作抗心律失常劑、鎮痛劑和氣管插管的輔助劑。 它是 Vaughan-Williams 分類中的叔胺，是一種抗心律失常藥。 利多卡因在麻醉學、心髒病學和疼痛管理中是一種有價值的工具。 在血漿中，利多卡因有 65% 的蛋白質與白蛋白和 α-1 酸性糖蛋白結合，與其他局部麻醉劑相比具有中等的作用持續時間。 利多卡因軟膏用於在某些醫療/牙科手術之前麻醉口腔和喉嚨的內層。

市場動態

市場主要參與者為擴大產品而進行的利多卡因軟膏研發活動的增加預計將在預測期內推動市場增長。 例如，2021 年 1 月，亞利桑那州的梅奧診所開始了一項臨床研究，比較兩種局部麻醉劑對面部點陣非燒蝕激光治療的效果。 2.5g 利多卡因 23%/丁卡因 7% 軟膏正在進行 2 期臨床試驗，7.5g 利多卡因 2.5%/丙胺卡因 2.5% 乳膏正在進行 3 期臨床試驗。 預計完工日期為 2023 年 1 月。

這項研究的主要特點

• 本報告對全球利多卡因軟膏市場進行了深入分析，展示了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。.
• 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 根據公司亮點、產品組合、主要亮點、績效和戰略等參數對全球利多卡因軟膏市場的主要參與者進行了概況分析。
• 本研究涉及的主要公司包括 Glenmark Pharmaceuticals U.S. Inc.、Teligent Inc.、Taro Pharmaceutical Industries Ltd.、CENTURA PHARMACEUTICALS INC.、Neon Laboratories Ltd.、ASTRAZENECA CANADA INC.、Novocol Pharma 和 Amneal Pharmaceuticals LLC。 、Alembic Pharmaceuticals Limited、Ascend Laboratories LLC、Liberty Pharmaceuticals, Inc.、Hi-Tech Pharmaceuticals、Aspen Pharmacare Australia Pty Ltd.、Sandoz AG、Zydus Healthcare Limited.、Quagen Pharmaceuticals、Zuche Pharmaceuticals Private Limited. 和 SEPTO DONT, Inc.
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 全球利多卡因軟膏市場報告迎合了該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球利多卡因軟膏市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按配方分類
  • 市場概況：按年齡組
  • 市場概況：按應用分類
  • 市場概況：按分銷渠道
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場吸引力分析
  • 市場機會
• 產品發布
• 合併、收購、聯合研究
• 管道分析
• 監管準則和合規性
• 政府乾預
• 害蟲分析
• 技術
• 品牌屬性映射
• 投資活動

第 4 章利多卡因軟膏的全球市場-冠狀病毒 (COVID-19) 大流行的影響

• 經濟影響
• COVID-19 的流行病學特徵
• 政府舉措

第 5 章全球利多卡因軟膏市場：按配方分類，2017-2030

• 內部使用
• 專題

第 6 章全球利多卡因軟膏市場：按年齡組劃分，2017-2030

• 兒科
• 成人

第 7 章全球利多卡因軟膏市場應用，2017-2030

• 昆蟲叮咬
• 曬傷
• 小裁員
• 口腔炎
• 其他

第 8 章。全球利多卡因軟膏市場：按分銷渠道，2017-2030 年（百萬美元

• 醫院藥房
• 零售藥房
• 在線藥店

第 9 章按地區分列的全球利多卡因軟膏市場，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第10章競爭格局

• Glenmark Pharmaceuticals U.S. Inc.
• Teligent Inc.
• Taro Pharmaceutical Industries Ltd.
• CENTURA PHARMACEUTICALS INC.
• Neon Laboratories Ltd
• ASTRAZENECA CANADA INC.
• Novocol Pharma
• Amneal Pharmaceuticals LLC
• Alembic Pharmaceuticals Limited
• Ascend Laboratories LLC
• Liberty Pharmaceuticals, Inc.
• Hi-Tech Pharmaceuticals
• Aspen Pharmacare Australia Pty Ltd.
• Sandoz AG
• Zydus Healthcare Limited
• Quagen Pharmaceuticals
• Zuche Pharmaceuticals Private Limited.
• SEPTODONT, Inc.

第 11 章章節

• 調查方法
• 關於出版商

Topical lidocaine ointment is used on various parts of the body to cause loss of sensation in patients undergoing certain medical procedures, such as surgery. It is also used to relieve pain and itching caused by conditions such as sun burn, poison ivy, poison oak, minor cuts and abrasions. It is also used to prevent and control pain during urethral surgery in both men and women.

Lidocaine is a local anesthetic commonly used for local anesthesia, but it is also used as an antiarrhythmic and analgesic drug and also used as an adjutant to endotracheal intubation. It is a tertiary amine and an antiarrhythmic drug according to the Vaughan-Williams classification. Lidocaine acts as a valuable tool in anesthesiology, cardiology, and pain management. In plasma, lidocaine has 65% of its protein bound to albumin and alpha 1 acid glycoprotein, giving it an intermediate duration of action compared to other local anesthetics. Lidocaine ointment are used to numb the lining of the mouth or throat before certain medical/dental procedures.

Market Dynamics

The increasing research and development activities of lidocaine ointment for product expansion by the key players in the market, which is expected to drive the market growth over the forecast period. For instance, in January 2021, The Mayo Clinic in Arizona has initiated a clinical study comparing two local anesthetics for fractional non-ablative laser treatment of the face. 2.5 g lidocaine 23%/tetracaine 7% ointment is in Phase 2 and 7.5 g lidocaine 2.5%/prilocaine 2.5% cream is in Phase 3 clinical trials. The scheduled completion date is January 2023.

Key features of the study:

• This report provides an in-depth analysis of the global lidocaine ointment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global lidocaine ointment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Glenmark Pharmaceuticals U.S. Inc., Teligent Inc., Taro Pharmaceutical Industries Ltd., CENTURA PHARMACEUTICALS INC., Neon Laboratories Ltd., ASTRAZENECA CANADA INC., Novocol Pharma, Amneal Pharmaceuticals LLC., Alembic Pharmaceuticals Limited, Ascend Laboratories LLC, Liberty Pharmaceuticals, Inc., Hi-Tech Pharmaceuticals, Aspen Pharmacare Australia Pty Ltd., Sandoz AG, Zydus Healthcare Limited., Quagen Pharmaceuticals, Zuche Pharmaceuticals Private Limited., and SEPTODONT, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global lidocaine ointment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lidocaine ointment market

Detailed Segmentation:

• Global Lidocaine Ointment Market, By Formulation:
  • Internal Use
  • Topical Use
• Global Lidocaine Ointment Market, By Age Group:
  • Children
  • Adult
• Global Lidocaine Ointment Market By Application:
  • Insect Bite
  • Sun Burn
  • Minor Cut
  • Mouth Sore
  • Others
• Global Lidocaine Ointment Market By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Lidocaine Ointment Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Glenmark Pharmaceuticals U.S. Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teligent Inc
  • Taro Pharmaceutical Industries Ltd.
  • CENTURA PHARMACEUTICALS INC
  • Neon Laboratories Ltd.
  • ASTRAZENECA CANADA INC
  • Novocol Pharma
  • Amneal Pharmaceuticals LLC.
  • Alembic Pharmaceuticals Limited
  • Ascend Laboratories LLC
  • Liberty Pharmaceuticals, Inc.
  • Hi-Tech Pharmaceuticals
  • Aspen Pharmacare Australia Pty Ltd.
  • Sandoz AG
  • Zydus Healthcare Limited.
  • Quagen Pharmaceuticals
  • Zuche Pharmaceuticals Private Limited.
  • SEPTODONT, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Formulation
  • Market Snapshot, By Age Group
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
• Product Launches
• Merger, Acquisition, Collaborations
• Pipeline Analysis
• Regulatory Guideline and Compliances
• Government Intervention
• PEST Analysis
• Technology Landscape
• Brand Attribute Mapping
• Investments

4. Global Lidocaine Ointment Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Government Initiatives

5. Global Lidocaine Ointment Market, By Formulation, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Internal Use
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Topical Use
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Lidocaine Ointment Market, By Age Group, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Children
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Lidocaine Ointment Market, By Application, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Insect Bite
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Sun Burn
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Minor Cut
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Mouth Sore
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Lidocaine Ointment Market, By Distribution Channel, 2017 - 2030, (US$ Million

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Lidocaine Ointment Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Glenmark Pharmaceuticals U.S. Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teligent Inc.
• Taro Pharmaceutical Industries Ltd.
• CENTURA PHARMACEUTICALS INC.
• Neon Laboratories Ltd
• ASTRAZENECA CANADA INC.
• Novocol Pharma
• Amneal Pharmaceuticals LLC
• Alembic Pharmaceuticals Limited
• Ascend Laboratories LLC
• Liberty Pharmaceuticals, Inc.
• Hi-Tech Pharmaceuticals
• Aspen Pharmacare Australia Pty Ltd.
• Sandoz AG
• Zydus Healthcare Limited
• Quagen Pharmaceuticals
• Zuche Pharmaceuticals Private Limited.
• SEPTODONT, Inc.

11. Section

• Research Methodology
• About Us